EMEKLİ, A. S. (2022). Multipl Skleroz Tedavisinde Yeni Oral Ajan Amiselimod. Türk Nöroloji Dergisi, Cilt: 23 - Sayı: 3, 148–149. https://ajindex.com/articles/636850
Kappos L, Arnold DL, Bar-Or A, Camm J, Derfuss T, Kieseier BC, Sprenger T, Greenough K, Ni P, Harada T. Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 2016;15:1148-1159.